For research use only. Not for therapeutic Use.
Mc-VC-PAB-SN38 (Cat.No:I015154) is an antibody-drug conjugate (ADC) designed for targeted cancer therapy. It consists of a potent anticancer drug, SN38, conjugated to a monoclonal antibody via a linker molecule. This ADC selectively binds to specific cancer cell surface antigens, delivering the cytotoxic payload directly to the tumor cells, minimizing off-target effects, and improving therapeutic efficacy.
| Catalog Number | I015154 |
| CAS Number | 1801838-28-7 |
| Molecular Formula | C₅₁H₅₈N₈O₁₃ |
| Purity | ≥95% |
| Reference | [1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337. |
